 MONTREAL, Jan. 19, 2021 GLOBE NEWSWIRE -- Theratechnologies Inc. Theratechnologies or the Company TSX: TH NASDAQ: THTX, a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce the closing of its previously-announced bought-deal public offering the Offering pursuant to which the Company issued 16,727,900 units of the Company the Units at a price of US2.75 per Unit equivalent to approximately C3.51 per Unit the Offering Price for aggregate gross proceeds to the Company of US46,001,725 equivalent to approximately C58,714,929, including the full exercise of the over-allotment option to purchase an additional 2,181,900 Units at the Offering Price. 